Kara Chew, MD, MS
Kara Chew, MD, MS joined the CARE Center in 2010 as part of her Infectious Diseases Fellowship at UCLA, following internal medicine residency and a junior clinical faculty position in the Division of General Internal Medicine at UCSF. She is a research investigator at CARE, with a focus on studies to improve the treatment and outcomes of those with Hepatitis C and HIV/Hepatitis C co-infection. She is also an HIV and Hepatitis C clinician. Dr. Chew enjoys playing tennis, hiking, and otherwise enjoying the great weather in Los Angeles.
Contact: kchew@mednet.ucla.edu
FEATURED PUBLICATIONS:
1. Deo, R., Choudhary, M. C., Glover, O. T., Ignacio, R. B., Boucau, J., Chew, K. W., Moser, C., Currier, J. S., Eron, J. J., Javan, A. C., Giganti, M. J., Aga, E., Gibbs, M., Cohen, T., Streicher, K., Soboleva, K., Fletcher, C. V., Daar, E. S., Greninger, A. L., Coombs, R. W., … Li, J. Z. (2025). Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy. Open forum infectious diseases, 12(9), ofaf542.
3. Psaras, C., Arah, O. A., Chew, K. W., Lee, S. J., Javanbakht, M., Nianogo, R. A., & Seamans, M. J. (2025). Opioid Agonist Therapy Adherence Trajectories Among Commercially and Publicly Insured People Living With Hepatitis C in the United States. Epidemiology (Cambridge, Mass.), 36(6), 820–829.
Last updated: 11/18/2025
